Last edition
News about "Generic Drugmakers"
Semaglutide Patent Expiry to Open Over USD 600 Million Opportunity for Generic Drugmakers
Industry estimates suggest that around 10 to 15 domestic and global drugmakers are likely to compete for this opportunity. In India, the introduction of generic semaglutide formulations, expected during the 2026–27 financial year, could generate incremental revenues of approximately USD 12–24 million within the branded formulations market.
Generic Drugmakers | 06/01/2026 | By Darshana | 327
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy